A carregar...
Metformin synergizes with rapamycin to inhibit the growth of pancreatic cancer in vitro and in vivo
Previous studies have suggested that metformin may improve the survival rate of patients with pancreatic cancer (PC) by regulating the adenosine monophosphate-activated protein kinase/mammalian target of rapamycin (mTOR) signaling pathway. Rapamycin specifically targets mTOR. In the present study, t...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5774390/ https://ncbi.nlm.nih.gov/pubmed/29434877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7444 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|